Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults and children aged 12 or older with metastatic Merkel cell carcinoma.
LAMPGEN ANALYSIS
Why it matters
FDA converted the earlier accelerated indication to traditional approval after fulfillment of its postmarketing requirement.
What research teams should watch
Use the stage and age limits from the approved label and distinguish this action from other Merkel cell indications.
PRIMARY RECORDS